Compounds > adenosine diphosphate
Page last updated: 2024-08-17

adenosine diphosphate and kc 764

adenosine diphosphate has been researched along with kc 764 in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Imai, S; Ino, T; Mitsuoka, Y; Momo, K; Nakamura, K; Ohkubo, H; Someya, K; Tachiiri, T1
Mase, K; Soga, T; Yasunaga, K; Yoshioka, M1

Other Studies

2 other study(ies) available for adenosine diphosphate and kc 764

ArticleYear
Effects of the new antiplatelet agent 2-methyl-3-(1,4,5,6-tetrahydronicotinoyl)pyrazolo[1,5-a]pyridine on platelet aggregation and thrombosis in experimental animals.
    Arzneimittel-Forschung, 1992, Volume: 42, Issue:1

    Topics: Adenosine Diphosphate; Animals; Arachidonic Acid; Aspirin; Bridged Bicyclo Compounds; Cyclooxygenase Inhibitors; Dogs; Electroencephalography; Female; Fibrinolytic Agents; Guinea Pigs; Humans; In Vitro Techniques; Indomethacin; Male; Mice; Mice, Inbred ICR; Nicotinic Acids; Platelet Aggregation; Platelet Aggregation Inhibitors; Rabbits; Rats; Rats, Inbred Strains; Respiration; Stomach Ulcer

1992
[Clinical and preclinical pharmacology of KC-764, a novel antiplatelet agent].
    Nihon rinsho. Japanese journal of clinical medicine, 1992, Volume: 50, Issue:2

    Topics: Adenosine Diphosphate; Aged; Arachidonic Acid; Bridged Bicyclo Compounds; Cerebral Infarction; Collagen; Cyclooxygenase Inhibitors; Dose-Response Relationship, Drug; Humans; Nicotinic Acids; Platelet Aggregation; Platelet Aggregation Inhibitors; Prostaglandins

1992